Close
CDMO Safety Testing 2026
Novotech

Berry to Showcase Latest Technologies for Fast-to-Market, Patient-Centric Solutions

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Made Smarter Advances AI in Manufacturing with New Toolkit

A new initiative from Made Smarter is aiming to...

Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal

Teva Pharmaceuticals has entered into a definitive agreement to...
- Advertisement -

Solutions for patient-centred drug delivery devices that enhance dosing, administration, and medication adherence will be the focus of Berry Global Healthcareโ€™s participation at this yearโ€™s RDD (Respiratory Drug Delivery) Europe Conference, taking place at the Estoril Congress Centre, Estoril (Lisbon), Portugal from May 6th to 9th.

The companyโ€™s Medical Devices team will present a wide range of ready-to-use platforms for inhalation therapies, which enhance the patient experience through ease of use and accurate drug delivery, as well as providing faster-to-market solutions. As part of Berryโ€™s โ€˜Dose Betterโ€™ initiative, all have been developed to deliver better healthcare outcomes by improving quality of care, while helping to reduce costs.

Latest innovations on show will include the RS01-X digital inhaler with built-in sensors and digital services to track inhaler use and help improve adherence and technique; the BerryHaler, a dual chamber dry powder inhaler with dose counter, designed to provide better patient access to and support the effective delivery of combination drugs; and the PneumoHaler, a breath-actuated, metered dose inhaler with dose indicator for the effective management of asthma and chronic obstructive pulmonary disease.

โ€œWe continue to invest in the latest healthcare technologies to provide dosing solutions that give end-users a safe and comfortable experience,โ€ said Arturo Cubi of Berry Global. โ€œOur attendance at RDD is a critical part of our ongoing NPD (new product development) programme, enabling us to engage with healthcare professionals to better understand current market demands and challenges.โ€

The RDD Conference will also give Berry the opportunity to demonstrate its over 50 yearsโ€™ experience as a contract manufacturer. The companyโ€™s fully integrated CDMO service provides a complete solution from product concept through manufacturing to final packaging, enabling it to design customised devices incorporating customer IP and proprietary platforms, and bring these bespoke drug delivery products quickly to market.

Toย  arrange an appointment at RDD, please email inhalation@berryglobal.com, or to learn more about Berryโ€™s range of medical devices, visit www.berryglobal.com/en/product/medical-devices.

Berry
Company Logo

Latest stories

Related stories

Made Smarter Advances AI in Manufacturing with New Toolkit

A new initiative from Made Smarter is aiming to...

Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal

Teva Pharmaceuticals has entered into a definitive agreement to...

BIO Asia – Taiwan 2026 to be Held in Mid-July in Taipei

Focusing on AI Integration to Unlock Opportunities for Accelerating...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป